Fieldpoint Private Securities’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Fieldpoint Private Securities’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$13K	Buy	+165	New	+$15.6K	﹤0.01%	696
2022 Q1	–	Sell	-100	Closed	-$11K	–	1781
2021 Q4	$11K	Hold	100	–	–	﹤0.01%	1070
2021 Q3	$11K	Hold	100	–	–	﹤0.01%	1033
2021 Q2	$10K	Buy	+100	New	+$9.2K	﹤0.01%	1043
2021 Q1	–	Sell	-450	Closed	-$33K	–	1675
2020 Q4	$33K	Buy	+450	New	+$33.4K	0.01%	563

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fieldpoint Private Securities's HZNP Position: Q2 2022 in Review

Fieldpoint Private Securities opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2022: 165 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #696 among its holdings. This is a return to the name: Fieldpoint Private Securities previously reported a position in HZNP as recently as Q4 2021.

Fieldpoint Private Securities first reported a position in HZNP in Q4 2020 and has held it in 5 quarters since. The position peaked at $33K in Q4 2020. 614 funds tracked by Wall St. Rank hold HZNP as of Q2 2022.

Fieldpoint Private Securities held 165 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $13K as of Q2 2022.
Horizon Therapeutics Public Limited Company Ordinary Shares was a new Fieldpoint Private Securities position in Q2 2022.
Horizon Therapeutics Public Limited Company Ordinary Shares made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #696 holding.
Fieldpoint Private Securities first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and has held it in 5 quarters since.
Fieldpoint Private Securities's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $33K in Q4 2020.
614 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.